Indian J Med Microbiol Close
 

Figure 2: Representative results of immunoblotting in examined groups: (a) an 82-year-old man with BP and Parkinson's disease without malignancies. Direct immunofluorescence revealed linear IgG4 (+) and C3 (+++) along the dermal-epidermal junction; ELISA anti-BP180 IgG 66.896 RU/mL, ELISA anti-BP230 IgG 114.511 RU/mL (cutoff = 20 RU/mL); (b) an elderly woman with BP without neurodegenerative disorders and malignancies. Direct immunofluorescence revealed linear IgG1 (+) and C3 (+++) along the dermal-epidermal junction; ELISA anti-BP180 IgG >200 RU/mL, ELISA anti-BP230 IgG 11.947 RU/mL (cutoff 20 RU/mL)

Figure 2: Representative results of immunoblotting in examined groups: (a) an 82-year-old man with BP and Parkinson's disease without malignancies. Direct immunofluorescence revealed linear IgG4 (+) and C3 (+++) along the dermal-epidermal junction; ELISA anti-BP180 IgG 66.896 RU/mL, ELISA anti-BP230 IgG 114.511 RU/mL (cutoff = 20 RU/mL); (b) an elderly woman with BP without neurodegenerative disorders and malignancies. Direct immunofluorescence revealed linear IgG1 (+) and C3 (+++) along the dermal-epidermal junction; ELISA anti-BP180 IgG >200 RU/mL, ELISA anti-BP230 IgG 11.947 RU/mL (cutoff 20 RU/mL)